1. Home
  2. NNDM vs AGMB Comparison

NNDM vs AGMB Comparison

Compare NNDM & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

SELL

Current Price

$1.41

Market Cap

606.7M

Sector

Technology

ML Signal

SELL

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

SELL

Current Price

$8.38

Market Cap

576.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NNDM
AGMB
Founded
2012
2017
Country
United States
Belgium
Employees
468
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
606.7M
576.2M
IPO Year
2015
2024

Fundamental Metrics

Financial Performance
Metric
NNDM
AGMB
Price
$1.41
$8.38
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $37.67
AVG Volume (30 Days)
★ 1.4M
139.5K
Earning Date
11-18-2026
11-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $102,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.00
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 77.30
N/A
52 Week Low
$1.19
$7.97
52 Week High
$2.32
$17.82

Technical Indicators

Market Signals
Indicator
NNDM
AGMB
Relative Strength Index (RSI) 33.08 31.21
Support Level $1.19 N/A
Resistance Level $1.64 $12.53
Average True Range (ATR) 0.05 0.81
MACD -0.02 0.01
Stochastic Oscillator 12.00 13.95

Price Performance

Historical Comparison
NNDM
AGMB

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: